Trainer, P J <br/><br/>
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant.  [electronic resource] 

 -  The New England journal of medicine  Apr 2000 
 - 1171-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0028-4793 
<br/><br/><label>Standard No.: </label>10.1056/NEJM200004203421604  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acromegaly--blood<br/>Adenoma--drug therapy<br/>Adult<br/>Autoantibodies--blood<br/>Double-Blind Method<br/>Female<br/>Human Growth Hormone--adverse effects<br/>Humans<br/>Insulin-Like Growth Factor I--metabolism<br/>Male<br/>Middle Aged<br/>Pituitary Neoplasms--drug therapy<br/>Receptors, Somatotropin--antagonists & inhibitors